US Stocks
/
ImmunityBio, Inc. Share Price
ImmunityBio, Inc. Share Price

ImmunityBio, Inc. Share Price

NASDAQ: IBRX | Mid Cap
$9.91
+$0.14 (1.48%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ImmunityBio, Inc. Stock Performance

Open
$9.63
Prev. Close
$9.77
Circuit Range
N/A
Day Range
$9.44 - $10.04
Year Range
$1.95 - $12.38
Volume
3,93,086
Average Traded
$9.79

ImmunityBio, Inc. Share Price Today

As of 9 October 2026, ImmunityBio, Inc.'s share price is $9.91. The stock opened at $9.63, compared to its previous close of $9.77. During today's trading session, ImmunityBio, Inc.'s share price traded between $9.44 and $10.04, with an average price of $9.74. Over the past 52 weeks, the stock has recorded a high of $12.38 and a low of $1.95. In terms of performance, ImmunityBio, Inc.'s share price has risen by 39.58% over the last six months and is up 314.64% on a year-on-year basis.

ImmunityBio, Inc. Share Price Chart

$9.44$10.04
L
Show Current Price
H

ImmunityBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.12B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.94
Revenue (TTM)
$113.29B
Return On Equity (TTM)
94.81%
Profit Margin
-310.18%
Debt to Equity
-0.40
Quarterly Earnings Growth YoY
-242.57%

ImmunityBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$32.06$38.29$44.21$51.24
Net Profit-$67.25-$61.94-$632.78-$230.38
Net Profit Margin-209.76%-161.77%-1431.31%-449.61%
Income ChangeN/A7.90%-921.60%63.59%

ImmunityBio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.24$0.62$14.75$113.29
Net Profit-$416.57-$583.20-$413.56-$351.40
Net Profit Margin-173570.83%-94064.52%-2803.80%-310.18%
Income ChangeN/A-40.00%29.09%15.03%

About ImmunityBio, Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

ImmunityBio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$9.27
$9.94
+4.91%
Sep 2026
$7.83
$9.47
+12.74%
Aug 2026
$7.17
$8.40
+17.15%
Jul 2026
$8.68
$7.17
-17.96%
Jun 2026
$7.38
$8.74
+16.30%
May 2026
$6.97
$7.51
+5.85%
Apr 2026
$7.53
$7.10
-7.13%
Mar 2026
$9.66
$7.64
-21.91%
Feb 2026
$6.29
$9.79
+56.14%
Jan 2026
$2.02
$6.27
+217.47%
Dec 2025
$2.38
$1.98
-16.14%
Nov 2025
$2.38
$2.35
-1.46%

IBRX Share Price FAQs

What is ImmunityBio, Inc. share price today?

chevron-up
ImmunityBio, Inc. share price today is $9.91 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ImmunityBio, Inc. stock?

chevron-up
The 52 week high of ImmunityBio, Inc. stock is $12.38, while the 52 week low is $1.95 as of 9 Oct '26.

What is IBRX's market capitalisation today?

chevron-up
IBRX market capitalisation is $9.12B as of October 9, 2026, at 1:30 am IST.

What is IBRX's net income for the last quarter?

chevron-up
IBRX's net income for the last quarter is -230.38B USD.

What is the 5 year returns of IBRX?

chevron-up
The 5 year returns of IBRX is 26.56% as on 9 Oct '26.

What is the high & low stock price of IBRX today?

chevron-up
IBRX stock price hit a high of $10.04 and low of $9.44 as of 9 Oct '26.

Can I buy IBRX shares in India?

chevron-up
Yes. You can buy IBRX in India by opening an international trading account.